Terms: = Leukemia AND CLIP1, ENSG00000130779, 6249, P30622, RSN, MGC131604, CYLN1, CLIP170, CLIP-170, CLIP
31 results:
1. Risk factors associated with infection-related mortality of Bacillus cereus bacteremia in hematologic disorders.
Shimada T; Ishikawa K; Kawai F; Yoneoka D; Mori N
Int J Hematol; 2023 Dec; 118(6):726-730. PubMed ID: 37848665
[TBL] [Abstract] [Full Text] [Related]
2. Biological and clinical perspectives of the actionable gene fusions and amplifications involving tyrosine kinase receptors in lung cancer.
Saigí M; Carcereny E; Morán T; Cucurull M; Domènech M; Hernandez A; Martinez-Cardús A; Pros E; Sanchez-Cespedes M
Cancer Treat Rev; 2022 Sep; 109():102430. PubMed ID: 35777135
[TBL] [Abstract] [Full Text] [Related]
3. A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation.
Hug N; Aitken S; Longman D; Raab M; Armes H; Mann AR; Rio-Machin A; Fitzgibbon J; Rouault-Pierre K; Cáceres JF
RNA; 2022 Sep; 28(9):1224-1238. PubMed ID: 35768279
[TBL] [Abstract] [Full Text] [Related]
4.
Kuželová K; Brodská B; Marková J; Petráčková M; Schetelig J; Ransdorfová Š; Gašová Z; Šálek C
Oncoimmunology; 2022; 11(1):2073050. PubMed ID: 35558161
[TBL] [Abstract] [Full Text] [Related]
5. Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Krivdova G; Voisin V; Schoof EM; Marhon SA; Murison A; McLeod JL; Gabra MM; Zeng AGX; Aigner S; Yee BA; Shishkin AA; Van Nostrand EL; Hermans KG; Trotman-Grant AC; Mbong N; Kennedy JA; Gan OI; Wagenblast E; De Carvalho DD; Salmena L; Minden MD; Bader GD; Yeo GW; Dick JE; Lechman ER
Cell Rep; 2022 Mar; 38(10):110481. PubMed ID: 35263585
[TBL] [Abstract] [Full Text] [Related]
6. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance.
Xu Y; Huangyang P; Wang Y; Xue L; Devericks E; Nguyen HG; Yu X; Oses-Prieto JA; Burlingame AL; Miglani S; Goodarzi H; Ruggero D
Cell; 2021 Sep; 184(20):5215-5229.e17. PubMed ID: 34559986
[TBL] [Abstract] [Full Text] [Related]
7. RNA m
Li Y; Sheng H; Ma F; Wu Q; Huang J; Chen Q; Sheng L; Zhu X; Zhu X; Xu M
Cell Death Dis; 2021 May; 12(5):479. PubMed ID: 33980824
[TBL] [Abstract] [Full Text] [Related]
8. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.
Antohe I; Tanasa MP; Dăscălescu A; Dănăilă C; Titieanu A; Zlei M; Ivanov I; Sireteanu A; Cianga P
Immunobiology; 2021 Jan; 226(1):152049. PubMed ID: 33352400
[TBL] [Abstract] [Full Text] [Related]
9. SURF: integrative analysis of a compendium of RNA-seq and clip-seq datasets highlights complex governing of alternative transcriptional regulation by RNA-binding proteins.
Chen F; Keleş S
Genome Biol; 2020 Jun; 21(1):139. PubMed ID: 32532357
[TBL] [Abstract] [Full Text] [Related]
10. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.
Elcheva IA; Wood T; Chiarolanzio K; Chim B; Wong M; Singh V; Gowda CP; Lu Q; Hafner M; Dovat S; Liu Z; Muljo SA; Spiegelman VS
Leukemia; 2020 May; 34(5):1354-1363. PubMed ID: 31768017
[TBL] [Abstract] [Full Text] [Related]
11. Transcriptome-wide analysis uncovers the targets of the RNA-binding protein MSI2 and effects of MSI2's RNA-binding activity on IL-6 signaling.
Duggimpudi S; Kloetgen A; Maney SK; Münch PC; Hezaveh K; Shaykhalishahi H; Hoyer W; McHardy AC; Lang PA; Borkhardt A; Hoell JI
J Biol Chem; 2018 Oct; 293(40):15359-15369. PubMed ID: 30126842
[TBL] [Abstract] [Full Text] [Related]
12. SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
Liang Y; Tebaldi T; Rejeski K; Joshi P; Stefani G; Taylor A; Song Y; Vasic R; Maziarz J; Balasubramanian K; Ardasheva A; Ding A; Quattrone A; Halene S
Leukemia; 2018 Dec; 32(12):2659-2671. PubMed ID: 29858584
[TBL] [Abstract] [Full Text] [Related]
13. Left Atrial Appendage Exclusion Using the Atriclip Device: A Case Series.
Page S; Hallam J; Pradhan N; Cowie B; Phan T; McGlade D; Rosalion A; Newcomb A; Yii M
Heart Lung Circ; 2019 Mar; 28(3):430-435. PubMed ID: 29402693
[TBL] [Abstract] [Full Text] [Related]
14. Herpesvirus saimiri MicroRNAs Preferentially Target Host Cell Cycle Regulators.
Guo YE; Oei T; Steitz JA
J Virol; 2015 Nov; 89(21):10901-11. PubMed ID: 26292323
[TBL] [Abstract] [Full Text] [Related]
15. IsomiR expression profiles in human lymphoblastoid cell lines exhibit population and gender dependencies.
Loher P; Londin ER; Rigoutsos I
Oncotarget; 2014 Sep; 5(18):8790-802. PubMed ID: 25229428
[TBL] [Abstract] [Full Text] [Related]
16. High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemia.
van den Ancker W; van Luijn MM; Chamuleau ME; Kelder A; Feller N; Terwijn M; Zevenbergen A; Schuurhuis GJ; van Ham SM; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Leuk Res; 2014 Jun; 38(6):691-3. PubMed ID: 24731748
[TBL] [Abstract] [Full Text] [Related]
17. Mixture models and wavelet transforms reveal high confidence RNA-protein interaction sites in MOV10 PAR-clip data.
Sievers C; Schlumpf T; Sawarkar R; Comoglio F; Paro R
Nucleic Acids Res; 2012 Nov; 40(20):e160. PubMed ID: 22844102
[TBL] [Abstract] [Full Text] [Related]
18. Promiscuous binding of invariant chain-derived clip peptide to distinct HLA-I molecules revealed in leukemic cells.
van Luijn MM; van de Loosdrecht AA; Lampen MH; van Veelen PA; Zevenbergen A; Kester MG; de Ru AH; Ossenkoppele GJ; van Hall T; van Ham SM
PLoS One; 2012; 7(4):e34649. PubMed ID: 22563374
[TBL] [Abstract] [Full Text] [Related]
19. Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemia.
van Luijn MM; Westers TM; Chamuleau ME; van Ham SM; Ossenkoppele GJ; van de Loosdrecht AA
Am J Pathol; 2011 Nov; 179(5):2157-61. PubMed ID: 21907692
[TBL] [Abstract] [Full Text] [Related]
20. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
[TBL] [Abstract] [Full Text] [Related]
[Next]
